Samarth Kulkarni, CEO: Crispr Therapeutics CRSP Sell · Filed 02/20

Trade details

Type: Insider sale
Amount: $366,324.86
Shares · price: 6,967 sh · $52.58 a share
Held after: 226,106 sh
Stock: Crispr Therapeutics CRSP
Person: Samarth KulkarniCEO
Trade date: 26/02/19
Filed: 26/02/20
Days to filing: 1 days

Sold 3.0% of holdings

Share of holding sold: 3.0%

Crispr Therapeutics trades, last 26 weeks

What else happened in Crispr Therapeutics around then

Filed or reported within 30 days of the trade day · 01/20~03/21

Samarth Kulkarni's recent trades

Samarth KulkarniCEO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$468.7K
10,020 sh
$468.7K
Filed 03/24
Traded 03/23
Samarth KulkarniCEO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$499.4K
10,349 sh
$499.4K
Filed 03/17
Traded 03/16
Samarth KulkarniCEO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$517.3K
9,798 sh
$517.3K
Filed 03/12
Traded 03/11
Samarth KulkarniCEO
Sell10b5-1 planCrispr Therapeutics
Sell10b5-1 plan
Crispr Therapeutics
CRSP
$3.6M
60,000 sh
$3.6M
Filed 01/22
Traded 01/22
Samarth KulkarniCEO
Sell10b5-1 planCrispr Therapeutics
Sell10b5-1 plan
Crispr Therapeutics
CRSP
$1.1M
21,433 sh
$1.1M
Filed 01/22
Traded 01/20